Welding equipment manufacturer Lincoln Electric (NASDAQ:LECO) beat Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 3.4% year on year to $1.02 billion. Its non-GAAP profit of $2.57 per share was 28.9% above analysts’ consensus estimates.
Hyatt Hotels (NYSE:H) Misses Q4 Sales Targets, Stock Drops
Hospitality company Hyatt Hotels (NYSE:H) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 3.5% year on year to $1.6 billion. Its non-GAAP profit of $0.42 per share was 46.8% below analysts’ consensus estimates.
Nova (NASDAQ:NVMI) Delivers Strong Q4 Numbers, Provides Optimistic Revenue Guidance for Next Quarter
Semiconductor quality control company Nova (NASDAQ:NVMI) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 45.1% year on year to $194.8 million. On top of that, next quarter’s revenue guidance ($210 million at the midpoint) was surprisingly good and 10.6% above what analysts were expecting. Its non-GAAP profit of $1.94 per share was 6.6% above analysts’ consensus estimates.
Texas Lawmakers Refile Bitcoin Reserve Bill, Expanding To Include Other Cryptocurrencies
Texas state lawmakers have reintroduced a bill aimed at establishing a Strategic Bitcoin Reserve, now designated as SB 21, which allows for investments in additional crypto.
Tokenization Platform Midas Expands Yield-Bearing Tokens With DeFi-Fund-Linked Offerings
The new Liquid Yield Tokens (LYT) offer a floating value based on DeFi funds, starting with Edge Capital, RE7 Capital, and MEV Capital.
Zoetis (NYSE:ZTS) Posts Q4 Sales In Line With Estimates But Stock Drops
Animal health company Zoetis (NYSE:ZTS) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 4.7% year on year to $2.32 billion. On the other hand, the company’s full-year revenue guidance of $9.3 billion at the midpoint came in 2.8% below analysts’ estimates. Its non-GAAP profit of $1.40 per share was 4.7% above analysts’ consensus estimates.
Bruker’s (NASDAQ:BRKR) Q4 Sales Top Estimates But Full-Year Sales Guidance Misses Expectations
Scientific instrument company Bruker (NASDAQ:BRKR). reported Q4 CY2024 results exceeding the market’s revenue expectations, with sales up 14.6% year on year to $979.6 million. On the other hand, the company’s full-year revenue guidance of $3.51 billion at the midpoint came in 1.8% below analysts’ estimates. Its non-GAAP profit of $0.76 per share was 3.2% above analysts’ consensus estimates.
Trump signs a plan for reciprocal tariffs on US trading partners, ushering in economic uncertainty
President Donald Trump on Thursday rolled out his plan to increase U.S. tariffs to match the tax rates that other countries charge on imports, possibly triggering a broader economic confrontation with allies and rivals alike as he hopes to eliminate any trade imbalances. "I’ve decided for purposes of fairness that I will charge a reciprocal tariff," Trump said in the Oval Office at the proclamation signing. Trump's Republican administration has insisted that its new tariffs would equalize the ability of U.S. and foreign manufacturers to compete, though under current law these new taxes would likely be paid by American consumers and businesses either directly or in the form of higher prices.
5 Things to Know Before the Stock Market Opens
News of the day for Feb. 13, 2025
Skeptics Circle European Stocks After $1 Trillion 2025 Rally
(Bloomberg) -- European investors are starting to wonder just how long the hot winning streak for the region’s stocks is going to last, even as possible talks to end the war in Ukraine send the market to fresh record highs.The Stoxx Europe 600 Index has risen 8% this year through Wednesday versus a gain of less than 3% for the US S&P 500. The outperformance has been fueled by what seems a convincing investment case: Shares are cheap, interest rates are going down and earnings are holding up.Skep